טוען...
Immunologic effects of rituximab on the human spleen in immune thrombocytopenia
Immune thrombocytopenia (ITP) is an autoimmune disease with a complex pathogenesis. As in many B cell–related autoimmune diseases, rituximab (RTX) has been shown to increase platelet counts in some ITP patients. From an immunologic standpoint, the mode of action of RTX and the reasons underlying its...
שמור ב:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Hematology
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3204911/ https://ncbi.nlm.nih.gov/pubmed/21876120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-03-344051 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|